This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3 PG Toniolo , M Levitz , A Zeleniuch-Jacquotte , S Banerjee , KL Koenig , RE Shore , P Strax & BS Pasternack (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87, 190–197.
4 H Adlercreutz , SL Gorbach , BR Goldin , MN Woods , JT Dwyer & E Hamalainen (1994) Estrogen metabolism and excretion in oriental and Caucasian women. J Natl Cancer Inst 86, 1076–1082.
5 GA Colditz (1999) Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy. J Womens Health 8, 347–357.
6 JG Liehr (2000) Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21, 40–54.
7 JG Liehr , WF Fang , DA Sirbasku & A Ari-Ulubelen (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 24, 353–356.
9 BT Zhu & AH Conney (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19, 1–27.
10 E Yared , TJ McMillan & FL Martin (2002) Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay. Mutagenesis 17, 345–352.
11 F Zhang , SM Swanson , RB van Breemen , X Liu , Y Yang , C Gu & JL Bolton (2001) Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. Chem Res Toxicol 14, 1654–1659.
13 MJ Tsai & BW O'Malley (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann Rev Biochem 63, 451–486.
14 RB Dickson , A Kasid , KK Huff , SE Bates , C Knabbe , D Bronzert , EP Gelmann & ME Lippman (1987) Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 β-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci USA 84, 837–841.
15 LK Leung & TT Wang (1999) Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7. Br J Cancer 81, 387–392.
16 CS Watson , AM Norfleet , TC Pappas & B Gametchu (1999) Rapid actions of estrogens in GH3/B6 pituitary tumour cells via a plasma membrane version of estrogen receptor-α. Steroids 64, 5–13.
18 K Toda , M Terashima , T Kawamoto , (1990) Structural and functional characterization of human aromatase P-450 gene. Eur J Biochem 193, 559–565.
19 N Harada , N Yoshimura & S Honda (2003) Unique regulation of expression of human aromatase in the placenta. J Steroid Biochem Mol Biol 86, 327–334.
20 KM Lee , J Abel , Y Ko , (2003) Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br J Cancer 88, 675–678.
22 H-J Jeong , YG Shin , L-H Kim & JM Pezzuto (1999) Inhibition of aromatase activity by flavonoids. Arch Pharm Res 22, 309–312.
23 YC Kao , C Zhou , M Sherman , CA Laughton & S Chen (1998) Molecular basis of the inhibition of human aromatase (estrogen synthethase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 106, 85–92.
24 JA Van Meeuwen , N Korthagen , PC de Jong , AH Piersma & M van den Berg (2007) (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture. Toxicol Appl Pharmacol 221, 372–383.
25 RW Brueggemeier , JC Hackett & ES Diaz-Cruz (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Reviews 26, 331–345.
26 S Chen , D Zhou , T Okubo , Y-C Kao & C Yang (1999) Breast tumor aromatase: functional role and transcriptional regulation. Endocr Relat Cancer 6, 149–156.
29 Y Wang , KW Lee , FL Chan , S Chen & LK Leung (2006) The red wine polyphenol resveratrol displays bi-level inhibition on aromatase in breast cancer cells. Toxicol Sci 92, 71–77.
30 T Mosmann (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55–63.
31 Y Wang , FL Chan , S Chen & LK Leung (2005) The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci 77, 39–51.
32 TG Peterson , L Coward , M Kirk , CN Falany & S Barnes (1996) The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis 17, 1861–1869.
33 S-M Heinonen , K Wahala & H Adlercreutz (2004) Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects. J Agric Food Chem 52, 6802–6809.
34 S Rice , HD Mason & SA Whitehead (2006) Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulose-luteal cells. J Steroid Biochem Mol Biol 101, 216–225.
35 ET Eng , D Williams , U Mandava , N Kirma , RR Tekmal & S Chen (2001) Suppression of aromatase (estrogen synthetase) by red wine phytochemicals. Breast Cancer Res Treat 67, 133–146.
37 JC Le Bail , C Pouget , C Fagnere , JP Basly , AJ Chulia & G Habrioux (2001) Chalcones are potent inhibitors of aromatase and 17(-hydroxysteroid dehydrogenase activities. Life Sci 68, 751–761.
40 ES Diaz-Cruz , CL Shapiro & RW Brueggemeier (2005) Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab 90, 2563–2570.
42 W Vanden Berghe , N Dijsselbloem , L Vermeulen , N Ndlovu , E Boone & G Haegeman (2006) Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-κB gene expression by soy isoflavones does not require estrogenic activity. Cancer Res 66, 4852–4862.
43 T Gotoh , K Yamada , H Yin , A Ito , T Kataoka & K Dohi (1998) Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res 89, 137–142.
44 H Mizunuma , K Kanazawa , S Ogura , S Otsuka & H Nagai (2002) Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer. Oncology 62, 78–84.
47 YJ Moon , K Sagawa , K Frederick , S Zhang & ME Morris (2006) Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J 8, E433–E442.